Inhaled Drug Delivery for Tuberculosis Therapy

Author： Muttil Pavan Wang Chenchen Hickey Anthony

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.26, Iss.11, 2009-11, pp. : 2401-2416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Emerging Formulation Design and Drug Delivery Systems for Inhaled Therapy)

Current Pharmaceutical Design, Vol. 21, Iss. 27, 2015-01 ,pp. : 3852-3853

Bentham Science Publishers

Access to resources Recommend Favorite

Tuberculosis susceptibility – implications for drug development and therapy

By Snell Noel J C

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1455-1460

Informa Healthcare

Access to resources Recommend Favorite

Microspheres as a drug delivery system in cancer therapy

By Cummings J.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 2, 1998-02 ,pp. : 153-171

Informa Healthcare

Access to resources Recommend Favorite

Smart Drug Delivery Systems in Cancer Therapy

Current Drug Targets, Vol. 19, Iss. 3, 2018-02 ,pp. : 202-212

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Delivery Systems for Brain Tumor Therapy

Current Pharmaceutical Design, Vol. 10, Iss. 12, 2004-05 ,pp. : 1341-1353

Bentham Science Publishers

Access to resources Recommend Favorite